Risperdal News: Sheller Quoted in Toronto Star
Stephen Sheller was quoted in a July 31, 2015 article discussing Risperdal research that was “manipulated by a drug company and understated the risks of a powerful antipsychotic used to treat kids with behavioural problems.” In the news story, pediatrician Denis Daneman says there was no intent on his part to exclude “significant results” from […]
STEPHEN SHELLER LIFETIME ACHIEVEMENT AWARD
Stephen Sheller was honored with a Lifetime Achievement Award Wednesday, May 20 2015 from American Lawyer Media’s daily newspaper, The Legal Intelligencer. The award was based on his record of verdicts and settlements, service to clients, dedication to the practice, and support of legal education. The Legal Intelligencer, May 20, 2015: “Stephen A. Sheller […]
#6 & #11 PA SETTLEMENTS 2014
American Lawyer Media’s Top Pennsylvania Verdicts and Settlements for 2014 reveals Sheller, P.C. in a familiar spot again in 2014. The firm has been at or near the top of the list for five of the last six years. This year the firm pulled both the #6 and #11 Top Settlements spots based on its […]
On TV: “American Hustle – Blowing the Whistle on Corporations”
Stephen Sheller appeared on The American Law Journal to discuss why, with historic False Claims Settlements in the billions, are CEOs not going to jail nor are corporations pleading to felony charges? Hosted by attorney Christopher Naughton, Sheller joined the panel including former Assistant U.S. Attorneys Joe Poluka of Blank Rome and Joseph Trautwein of Trautwein […]
ON TV: Sheller on How Pharma Faring in Courts
ON TV: Stephen A. Sheller appeared on “How is Pharma Faring in the Courts?” on The American Law Journal The American Law Journal on CNN News Philadelphia affiliate WFMZ-TV 2015-04-06
TV: SHELLER ON PHARMA & COURTS
Stephen Sheller appeared on the Philadelphia CNN-News affiliate WFMZ-TV program The American Law Journal on “How Is Pharma Faring in the Courts?” Host Christopher Naughton welcomed plaintiff’s attorneys Christopher Placitella, Esq. of Cohen Placitella & Roth, Stephen Sheller of Sheller, P.C., corporate defense counsel Terry Henry of Blank Rome and Bloomberg News Reporter Jef Feeley. In an opening feature report, […]
#1 PA V&S 2013-2014
Sheller, P.C. had the largest settlement in Pennsylvania in 2013-2014 as published in American Lawyer Media’s Legal Intelligencer newspaper. The $2.2 billion settlement with Janssen Pharmaceuticals, a division of Johnson & Johnson, was a qui tam case where Sheller, P.C. represented the whistleblower who brought the qui tam charges. With the U.S. Department of Justice, […]
In The Philadelphia Inquirer: Sheller $2.2 Billion J&J Pharma Settlement
J&J to pay $2.2B for Improper Promotion of Risperdal BY DAVID SELL WASHINGTON – Health-care giant Johnson & Johnson agreed Monday to plead guilty to a criminal misdemeanor charge and pay $2.2 billion to settle allegations that it illegally promoted the use of its antipsychotic drugs for unapproved uses, including for children and the elderly. […]
HUMANITARIAN OF THE YEAR, CCHR
Stephen Sheller was honored as “Humanitarian of the Year” by the Citizens Commission on Human Rights (CCHR). The black tie event was held at the Los Angeles Westin Bonaventure February 28, 2015. The introduction to his award: “CCHR’s first human rights award winner is a renowned attorney Stephen Sheller. His Philadelphia law firm opposes some […]
J&J Loses Trial Over Risperdal and Male Breast
The Wall Street Journal Pharmalot Blog 2015-02-24 In a setback to Johnson & Johnson, a Philadelphia jury decided the health care giant must pay $2.5 million in damages for failing to warn that its Risperdal antipsychotic could cause gynecomastia, which is abnormal development of breasts in males. The lawsuit was brought by the family of […]
